Can you get shingles without a dermatomal rash?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Herpes Zoster Without Dermatomal Rash

Yes, you can get shingles without a dermatomal rash, a condition known as zoster sine herpete (shingles without rash). 1

Clinical Presentation of Atypical Herpes Zoster

  • Zoster sine herpete is characterized by radicular pain in a dermatomal distribution without the typical vesicular eruption 1
  • Patients may experience prodromal symptoms similar to typical herpes zoster, including malaise, headache, and abnormal skin sensations, but without subsequent rash development 2
  • Some patients may present with nonspecific lesions that do not initially have the vesicular appearance typical of herpes zoster 3
  • The rash might be atypical, localized, faint, or evanescent in some cases, making diagnosis challenging 3

Risk Factors for Atypical Presentations

  • Immunocompromised status significantly increases the risk of developing atypical presentations of herpes zoster 4
  • Patients with conditions that decrease cell-mediated immunity are 20 to 100 times more likely to develop herpes zoster, including atypical forms 2
  • Advanced age is associated with increased risk of herpes zoster reactivation and atypical presentations 4
  • Recipients of blood, bone marrow, or solid organ transplants are at higher risk for developing herpes zoster with potential atypical manifestations 3, 4

Diagnostic Considerations

  • In cases of suspected zoster sine herpete, diagnostic confirmation is challenging and may require virus isolation and serological tests 5
  • Tzanck smear showing giant cells can be diagnostic for herpesvirus infection even in atypical presentations 3
  • Vesicle fluid specimens (if any lesions are present) can be obtained for immunofluorescence antigen testing, culture, or PCR to confirm diagnosis 3
  • VZV DNA may be detected in blood mononuclear cells of elderly individuals even in the absence of skin lesions 1

Clinical Implications and Management

  • High-dose IV acyclovir is recommended for immunocompromised hosts with suspected herpes zoster, even without typical rash 3, 6
  • Oral antiviral therapy with acyclovir, valacyclovir, or famciclovir should be initiated as soon as possible after diagnosis, even in atypical presentations 6
  • Treatment should ideally begin within 72 hours of symptom onset to reduce viral replication and prevent complications 2
  • Lack of rash or late-onset rash in herpes zoster has been associated with delays in diagnosis and increased mortality in some cases 3

Potential Complications

  • Postherpetic neuralgia can develop even in cases without visible rash, occurring in approximately 20% of herpes zoster patients 2
  • Immunocompromised patients may develop chronic complications with persistent viral replication, even with atypical presentations 3, 4
  • Secondary bacterial and fungal superinfections can occur, particularly in immunocompromised hosts 3
  • Neurological complications including various motor neuropathies, encephalitis, and Guillain-Barré syndrome can occur with or without typical rash 5

Special Considerations

  • Elderly patients may develop painless herpes zoster, another atypical presentation that can further complicate diagnosis 7
  • Consider herpes zoster in the differential diagnosis for patients with unexplained dermatomal pain, even without visible rash 1
  • VZV can produce neurologic and visceral diseases in the absence of rash or radicular pain 1
  • Antiviral resistance should be investigated if symptoms persist despite appropriate therapy, especially in immunocompromised patients 4

References

Research

Varicella-zoster virus reactivation without rash.

The Journal of infectious diseases, 1992

Guideline

Herpes Zoster Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Herpes Zoster Reactivation in Individuals with Varicella Antibodies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.